Apoptotic caspases cleave DRP1 to promote mitochondrial fusion and anti-viral immune responses
This study reveals that apoptotic caspases cleave the mitochondrial fission factor DRP1 during viral infection to induce mitochondrial elongation and MAVS aggregation, thereby enhancing anti-viral immune responses.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every living cell, there is a vast network of tiny power plants called mitochondria. These organelles do more than just generate energy; they act as central command centers for the cell's immune system, helping to detect and fight off invading viruses. To function correctly, these power plants must constantly change their shape, breaking apart into smaller pieces or fusing together into long, connected strands. This dynamic reshaping is controlled by a specific protein called DRP1, which acts like a pair of molecular scissors, cutting the mitochondria to keep them fragmented. For decades, scientists believed that when a virus invaded, the cell's primary defense was to trigger a form of programmed cell death, known as apoptosis, to sacrifice the infected cell and stop the virus from spreading. This process involves a family of enzymes called caspases, which cut up cellular components to dismantle the cell. It was widely thought that these same enzymes might also accidentally damage the cell's immune signaling, helping the virus win. However, a new study suggests that the relationship between these enzymes and the immune system is far more complex and surprisingly helpful than previously imagined.
Researchers at the Wuhan Institute of Virology and Changzhi Medical College have discovered that in the case of Rift Valley fever virus, the very enzymes meant to destroy the cell actually help the immune system fight back. When the virus enters a cell, it triggers the activation of these caspase enzymes. Instead of simply cutting up the immune system's messengers, the enzymes target the DRP1 protein. By cutting DRP1, the enzymes disable the cell's ability to break apart its mitochondria. As a result, the mitochondria fuse together into long, elongated strands. This change in shape is not a sign of failure; rather, it creates a better platform for the cell's immune signals to gather and amplify. The study shows that these long, fused mitochondria allow a key immune protein, called MAVS, to clump together more effectively. This aggregation acts as a powerful signal booster, turning on the production of antiviral proteins that can stop the virus from replicating.
The team demonstrated this mechanism by infecting human cells with Rift Valley fever virus and observing the changes under a microscope. They saw that the mitochondria, which usually look like a scattered collection of small dots, stretched out into long threads. They traced this change to the viral protein NSs, which activates the caspase enzymes. When the researchers blocked these enzymes with a chemical inhibitor, the mitochondria remained short and fragmented, and the immune response was weak. Conversely, when they prevented the DRP1 protein from being cut, the mitochondria stayed fragmented, and the cell failed to mount a strong defense. This confirmed that the cutting of DRP1 was the essential step that allowed the mitochondria to elongate and the immune system to activate.
To ensure this was not a fluke specific to one virus, the scientists tested the same process with other common viruses, including influenza A, Sendai virus, and herpes simplex virus. In every case, the infection triggered the activation of caspase enzymes, which then cut the DRP1 protein, leading to mitochondrial elongation and a stronger immune response. The researchers also created a version of the DRP1 protein that could not be cut by the enzymes. When cells were equipped with this uncuttable version, the mitochondria could not elongate, and the immune response was significantly weaker, allowing the viruses to replicate more easily. This proved that the natural cutting of DRP1 is a deliberate and effective strategy the body uses to enhance its defenses.
This discovery challenges the old view that the cell's self-destruct mechanism is purely a last resort that might accidentally harm the immune system. Instead, it reveals a dual role for these enzymes: they can dismantle the cell to stop viral spread, but they can also reorganize the cell's internal structure to boost the immune signal before the cell dies. The study suggests that the body has evolved a sophisticated way to use the tools of cell death to strengthen its fight against infection. By cutting a specific protein, the cell transforms its power plants into a unified network, creating a more effective launchpad for its antiviral weapons. This finding opens a new window into how the body balances the delicate line between self-destruction and self-defense, showing that even in the face of an attack, the cell's internal machinery can be repurposed to fight back with greater strength.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.